tamibarotene has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miwako, I; Shudo, K | 1 |
| Hoshikawa, S; Ito, S; Mori, K; Morohoshi, K; Nakagawa, Y; Ozaki, H; Takahashi, Y; Yoshida, K | 1 |
2 other study(ies) available for tamibarotene and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Oral administration of synthetic retinoid Am80 inhibits the development of type 1 diabetes in non-obese diabetic (NOD) mice.
Topics: Administration, Oral; Animals; Benzoates; Diabetes Mellitus, Type 1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycosuria; Mice; Mice, Inbred NOD; Pancreas; Recombinant Proteins; Retinoids; Salivary Glands; Survival Analysis; Tetrahydronaphthalenes | 2009 |
Effects of synthetic retinoid Am80 on iodide-induced autoimmune thyroiditis in nonobese diabetic mice.
Topics: Administration, Oral; Animals; Autoantibodies; Benzoates; Diabetes Mellitus, Type 1; Drug Interactions; Interferon-gamma; Lymphocyte Count; Mice; Mice, Inbred NOD; Retinoids; Spleen; T-Lymphocytes; Tetrahydronaphthalenes; Thyroiditis, Autoimmune | 2011 |